| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 01/28/2004 | EP1383766A1 Disubstituted 1,7-guanines |
| 01/28/2004 | CN1471536A Chemokine receptor antagonsis and method of use thereof |
| 01/28/2004 | CN1471535A Tricyclic derivatives of indole with antiangiogenic activity |
| 01/27/2004 | CA2188110C Pesticidal dry powder formulation enriched in azadirachtin upto 88%, an emulsifiable concentrate enriched upto 30% of azadirachtin and a process for preparing such formulation andconcentrate from neem seed/kernel |
| 01/22/2004 | WO2004007498A2 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 01/22/2004 | WO2004007465A1 Method for producing imidazolium salts |
| 01/22/2004 | WO2004006836A2 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 01/22/2004 | WO2003059911A3 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS |
| 01/22/2004 | WO2003059356A3 Novel anti-infectives |
| 01/22/2004 | US20040014982 For use as fungicides or cytostatic agents |
| 01/22/2004 | US20040014787 Hormone inhibitors; controlling fertility |
| 01/22/2004 | US20040014742 Antiinflammatory agents; viricides |
| 01/22/2004 | DE10229218A1 Alkylendioxythiophen-Dimere und Trimere Alkylenedioxythiophene dimers and trimers |
| 01/22/2004 | CA2509821A1 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 01/22/2004 | CA2492022A1 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 01/21/2004 | EP1382608A1 Sulfate of cephem compound |
| 01/21/2004 | EP1382607A2 Prenyl transferase inhibitors |
| 01/21/2004 | EP1381615A2 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- 1,4]DIOXINO 2,3-e]INDOLE |
| 01/21/2004 | EP1381614A2 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO 2,3-f]QUINOXALINE |
| 01/21/2004 | EP1381613A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused- 1,4]-benzodioxans |
| 01/21/2004 | EP1381612A1 Antidepressant aza-heterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline |
| 01/21/2004 | EP1381392A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 01/21/2004 | CN1469878A Aza-and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| 01/20/2004 | US6680313 1-hydroxyethyl-2(imidazo(5,1b)thiazol-2-yl-1-carbapen-2-em-3-c carboxylic acid or salt, excellent antibiotic activity against a wide spectrum of bacteria |
| 01/20/2004 | US6680025 Device and method for photoactivation |
| 01/15/2004 | WO2004006355A2 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | WO2004006354A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | WO2004006352A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | WO2004005406A2 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | WO2004005288A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | US20040010006 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene |
| 01/15/2004 | US20040009998 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 01/15/2004 | US20040009983 Azaindoles |
| 01/15/2004 | US20040009368 An anode, a hole transporting layer, a light emitting layer, and electron transporting layer and a cathode |
| 01/15/2004 | CA2492692A1 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | CA2492690A1 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | CA2492689A1 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | CA2492688A1 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | CA2492686A1 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/14/2004 | EP1379528A1 Pyrazolopyrimidines as therapeutic agents |
| 01/14/2004 | EP1379520A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 01/14/2004 | CN1468238A Substituted pyrazoles |
| 01/14/2004 | CN1468237A Substituted pyrazoles |
| 01/13/2004 | US6677331 Having substituted imidazo(5,1-b)thiazole group at 2-position; microbiocides against beta-lactamase producing bacteria and resistant pseudomonas |
| 01/13/2004 | CA2172726C A1 adenosine receptor antagonists |
| 01/08/2004 | WO2004002992A1 Compounds |
| 01/08/2004 | WO2004002986A2 Novel benzimidazole derivatives |
| 01/08/2004 | WO2004002531A1 Remedies for diseases caused by vascular contraction or dilation |
| 01/08/2004 | WO2003055856A3 BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 01/08/2004 | US20040006101 Quinolinone derivatives |
| 01/08/2004 | US20040006098 Induce cytokine biosynthesis in animals |
| 01/08/2004 | US20040006095 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 01/08/2004 | US20040006083 Pyrazolopyrimidines as therapeutic agents |
| 01/07/2004 | EP1378241A1 Pharmaceutical compositions comprising arsenic for the treatment of melanoma |
| 01/07/2004 | EP1378240A2 Pharmaceutical compositions comprising arsenic for the treatment of multiple myeloma |
| 01/07/2004 | EP1377586A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 01/07/2004 | EP1377578A1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 01/06/2004 | US6673928 Metalating an indolizine not having a substituent at the 5-position with a metal compound and, reacting with a boric acid ester compund to form the end porduct |
| 01/06/2004 | US6673927 Farnesyl transferase inhibitors |
| 01/06/2004 | US6673811 Treatment of anxiety, depression, sleep disorder, attention deficit disorder, alzheimer's dementia, or short-term memory loss |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/02/2004 | EP1375560A1 Alkylenedioxythiophene dimers and trimers |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 01/02/2004 | EP1373269A1 Jun kinase inhibitors |
| 01/01/2004 | US20040002611 Synthesis of spiro esters, spiro ortho carbonates, and intermediates |
| 01/01/2004 | US20040002528 CBI analogs of CC-1065 and the duocarmycins |
| 01/01/2004 | US20040002518 Anticancer agents; tyrosine kinase inhibitor; wound healing agents |
| 12/31/2003 | WO2004000324A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/30/2003 | US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 12/30/2003 | US6670364 Antagonists of MCP-1 function and methods of use thereof |
| 12/30/2003 | US6670357 Antiinflammatory agents |
| 12/25/2003 | US20030236405 7-hetero-bicyclo[2.2.1]-heptanes |
| 12/25/2003 | US20030236278 Serotonine receptors antagonist; central nervous system disorders |
| 12/25/2003 | US20030236270 Central nervous system disorders |
| 12/25/2003 | US20030236264 Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease |
| 12/25/2003 | US20030236263 Chemical compounds |
| 12/25/2003 | US20030235632 Heterocyclic ethers obtained from grapefruit juices, used as first pass effect antgonists; dietetics |
| 12/24/2003 | WO2003106446A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | WO2003105666A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 12/24/2003 | WO2002100858A8 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 12/24/2003 | CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | CA2489179A1 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 12/18/2003 | WO2003104236A1 Calcitonin gene related peptide receptor antagonists |
| 12/18/2003 | WO2003104233A1 4,5-dihydro-imidazo (4,5,1-ij) quinolin-6-ones derivatives and their use as poly (adp-ribosyl) transferase (parp) inhibitors |
| 12/18/2003 | WO2003103661A1 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES |
| 12/18/2003 | WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 12/18/2003 | WO2003103574A2 Protease inhibitors |
| 12/18/2003 | WO2003064431A3 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 12/18/2003 | WO2003050064B1 Mitotic kinesin inhibitors |
| 12/18/2003 | WO2003044021A3 Substituted indolizine-like compounds and methods of use |
| 12/18/2003 | US20030232875 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 12/18/2003 | US20030232838 6-phenylpyrrolopyrimidinedione derivatives |
| 12/18/2003 | CA2488567A1 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 12/17/2003 | EP1189889B1 Compositions and methods for inhibiting cell death |
| 12/17/2003 | EP1162970B1 Anti-inflammatory uses of manzamines |
| 12/17/2003 | CN1462303A Double-spiro organic compounds and electric-field luminescent devices |
| 12/17/2003 | CN1462274A Triazolo-epothilones |
| 12/17/2003 | CN1462269A Fused azepine drivatives and their use as antidiuretic agents |
| 12/17/2003 | CN1131230C Tricyclic delta 3-piperidines as alpha 2-antagonists |
| 12/11/2003 | WO2003101990A1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |